Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis

Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies

(2015) W. J. Sandborn et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Su2080 Efficacy of Budesonide MMx(r) 6 mg QD for the Maintenance of Remission in Patients With Ulcerative Colitis: Results From a Phase III, 12 Month Safety and Extended use Study

(2015) William J. Sandborn et al.   GASTROENTEROLOGY

Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis

(2014) S. Danese et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Case-control study of factors that trigger inflammatory bowel disease flares

(2014) Linda A Feagins   WORLD JOURNAL OF GASTROENTEROLOGY

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

(2013) Simon P L Travis et al.   GUT

Bioavailability profile of Uceris MMX extended-release tablets compared with Entocort EC capsules in healthy volunteers

(2013) Andrew Nicholls et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Once-Daily MMX® Mesalamine for Endoscopic Maintenance of Remission of Ulcerative Colitis

(2012) Geert D'Haens et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis

(2012) Debanjali Mitra et al.   BMC GASTROENTEROLOGY

Direct Health Care Insurer and Out-of-Pocket Expenditures of Inflammatory Bowel Disease: Evidence from a US National Survey

(2012) Candace Gunnarsson et al.   DIGESTIVE DISEASES AND SCIENCES

Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study

(2012) William J. Sandborn et al.   GASTROENTEROLOGY

Induction of remission with oral budesonide MMX® (9 mg) tablets in oatients with mild to moderate, active Ulcerative Colitis: A multicenter, open-label efficacy and safety study

(2012) Simon Travis et al.   INFLAMMATORY BOWEL DISEASES

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Ulcerative colitis

(2012) Ingrid Ordás et al.   LANCET

The burden of inflammatory bowel disease on health care utilization and quality of life

(2012) Ellinoora Nurmi et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

(2011) Natalie A. Molodecky et al.   GASTROENTEROLOGY

Cost Effectiveness of Treatments for Inflammatory Bowel Disease

(2011) Keith Bodger   PHARMACOECONOMICS

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

(2010) Asher Kornbluth et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

New Drug Delivery Systems in Inflammatory Bowel Disease: MMX™ and Tailored Delivery to the Gut

(2010) G. Fiorino et al.   CURRENT MEDICINAL CHEMISTRY

Oral budesonide for maintenance of remission of Crohn’s disease: a pooled safety analysis

(2008) G. R. LICHTENSTEIN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Immunosuppressant Medications and Mortality in Inflammatory Bowel Disease

(2008) James D. Lewis et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults

(2008) Michael D. Kappelman et al.   GASTROENTEROLOGY

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

(2008) M A Kamm et al.   GUT